Effect of FID 114675A on Lens Wettability

Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT01342107
Collaborator
(none)
66
1
2
2
32.4

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate lens wettability of contact lenses when used with an investigational multi-purpose disinfecting solution.

Condition or Disease Intervention/Treatment Phase
  • Device: FID 114675A multi-purpose disinfecting solution (MPDS)
  • Device: Soft contact lens
  • Device: Blister pack solution
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Alcon Multi-Purpose Disinfecting Solution (MPDS) on Lens Wettability
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Feb 1, 2011
Actual Study Completion Date :
Feb 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: FID 114675A

Contact lens soaked overnight in an investigational multi-purpose disinfecting solution randomly assigned to one eye, with contact lens removed directly from the blister pack assigned to the fellow eye for contralateral wear. Both products worn for one day, 16 hours.

Device: FID 114675A multi-purpose disinfecting solution (MPDS)
Investigational multi-purpose disinfecting solution intended for use as a cleaning, reconditioning, rinsing, disinfecting, and storage solution for silicone hydrogel and soft contact lenses.

Device: Soft contact lens
Soft hydrogel or silicone hydrogel contact lens matching subject's pre-study lens, including parameters, worn 16 hours on day of dispense.
Other Names:
  • Acuvue2
  • PureVision
  • Acuvue Oasys
  • Active Comparator: Blister Pack

    Contact lens removed directly from the blister pack randomly assigned to one eye, with contact lens soaked overnight in an investigational multi-purpose disinfecting solution assigned to the fellow eye for contralateral wear. Both products worn for one day, 16 hours.

    Device: Soft contact lens
    Soft hydrogel or silicone hydrogel contact lens matching subject's pre-study lens, including parameters, worn 16 hours on day of dispense.
    Other Names:
  • Acuvue2
  • PureVision
  • Acuvue Oasys
  • Device: Blister pack solution
    Commercially approved storage solution as found in the contact lens blister pack.
    Other Names:
  • Acuvue2
  • PureVision
  • Acuvue Oasys
  • Outcome Measures

    Primary Outcome Measures

    1. Lens Wettability [16 hours]

      As assessed by the investigator during slit-lamp exam and rated on a 0-4 scale, with 0 = a smooth uniformly reflecting wettable surface; 1 = a coarse hazy wettable surface which seems resolved momentarily with each blink and becomes exacerbated with staring; 2 = one stable dry (non-wetting) area of some magnitude; 3 = more than one stable dry (non-wetting) area of some magnitude; 4 = non-wettable lens surface of severe magnitude. Lenses with a Grade 0 or 1 were rated as wettable and reported as a percentage of total lenses evaluated.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years or age or older with normal eyes, other than correction for refractive error.

    • At least 5 days successful daily wear (minimum 8 hours per day) of PureVision®, Acuvue® Oasys™, or Acuvue® 2 contact lenses prior to Visit 1

    • Vision correctable to 20/30 (Snellen) or better in each eye at distance with lenses at Visit 1 (Day 0 - Baseline).

    • Grade 0 or Grade 1 wettability in both eyes after at least 15 minutes of lens wear at Visit 1 (Day 0 - Baseline).

    • Other protocol-defined inclusion criteria may apply.

    Exclusion Criteria:
    • Any ocular or systemic medical condition that may, in the opinion of the investigator, preclude safe administration of the test articles or affect the results of the study.

    • Need to wear contact lenses on an extended wear basis (i.e., overnight) during the study.

    • Use of products other than a multi-purpose solution or hydrogen peroxide solution, including daily and enzyme cleaners and saline rinses, for lens care at least 7 days prior to Visit 1 (Day 0 - Baseline).

    • Use of over-the-counter (OTC) or prescribed topical ocular medications within 7 days prior to Visit 1. Use of lens rewetting drops is acceptable.

    • History or current ocular infections or ocular inflammatory events.

    • Ocular surgery within the past year.

    • Participation in any investigational study within the past 30 days.

    • Other protocol-defined exclusion criteria may apply.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Contact Alcon Call Center for Trial Locations Fort Worth Texas United States 76314

    Sponsors and Collaborators

    • Alcon Research

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01342107
    Other Study ID Numbers:
    • C-10-024
    First Posted:
    Apr 27, 2011
    Last Update Posted:
    Apr 13, 2012
    Last Verified:
    Mar 1, 2012
    Keywords provided by Alcon Research
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title FID 114675A Blister Pack
    Arm/Group Description Contact lens soaked overnight in an investigational multi-purpose disinfecting solution randomly assigned to right eye, with contact lens removed directly from the blister pack assigned to left eye for contralateral wear. Contact lens removed directly from the blister pack randomly assigned to right eye, with contact lens soaked overnight in an investigational multi-purpose disinfecting solution assigned to left eye for contralateral wear.
    Period Title: Overall Study
    STARTED 34 32
    COMPLETED 34 32
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title FID 114675A Blister Pack Total
    Arm/Group Description Contact lens soaked overnight in an investigational multi-purpose disinfecting solution randomly assigned to right eye, with contact lens removed directly from the blister pack assigned to left eye for contralateral wear. Contact lens removed directly from the blister pack randomly assigned to right eye, with contact lens soaked overnight in an investigational multi-purpose disinfecting solution assigned to left eye for contralateral wear. Total of all reporting groups
    Overall Participants 34 32 66
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    36.6
    (10.76)
    37.3
    (12.34)
    36.9
    (11.47)
    Sex: Female, Male (Count of Participants)
    Female
    25
    73.5%
    22
    68.8%
    47
    71.2%
    Male
    9
    26.5%
    10
    31.3%
    19
    28.8%

    Outcome Measures

    1. Primary Outcome
    Title Lens Wettability
    Description As assessed by the investigator during slit-lamp exam and rated on a 0-4 scale, with 0 = a smooth uniformly reflecting wettable surface; 1 = a coarse hazy wettable surface which seems resolved momentarily with each blink and becomes exacerbated with staring; 2 = one stable dry (non-wetting) area of some magnitude; 3 = more than one stable dry (non-wetting) area of some magnitude; 4 = non-wettable lens surface of severe magnitude. Lenses with a Grade 0 or 1 were rated as wettable and reported as a percentage of total lenses evaluated.
    Time Frame 16 hours

    Outcome Measure Data

    Analysis Population Description
    Intent to treat. All subject-eyes that received contact lenses pre-soaked per treatment regimen and completed Visit 2 (Day 1 - Exit at 16 hours) were included in the ITT data set.
    Arm/Group Title FID 114675A Blister Pack
    Arm/Group Description Contact lens soaked overnight in an investigational multi-purpose disinfecting solution and inserted on day of dispense for 16 hours of wear. Contact lens removed directly from the blister pack and inserted on day of dispense for 16 hours of wear.
    Measure Participants 66 66
    Number (95% Confidence Interval) [percentage of lenses]
    95.5
    97.0

    Adverse Events

    Time Frame Adverse events were collected for the duration of the study: October 11, 2010 through February 2, 2011.
    Adverse Event Reporting Description All subjects who received contact lenses pre-soaked per treatment regimen were evaluable for the safety analysis.
    Arm/Group Title FID 114675A Blister Pack
    Arm/Group Description Contact lens soaked overnight in an investigational multi-purpose disinfecting solution and inserted on day of dispense for 16 hours of wear. Contact lens removed directly from the blister pack and inserted on day of dispense for 16 hours of wear.
    All Cause Mortality
    FID 114675A Blister Pack
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    FID 114675A Blister Pack
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/66 (0%) 0/66 (0%)
    Other (Not Including Serious) Adverse Events
    FID 114675A Blister Pack
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/66 (0%) 0/66 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    Alcon reserves the right of prior review of any publication or presentation of information related to the study.

    Results Point of Contact

    Name/Title Director of Alcon Clinical
    Organization Alcon Research, Ltd.
    Phone 1-888-451-3937
    Email medinfo@alconlabs.com
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01342107
    Other Study ID Numbers:
    • C-10-024
    First Posted:
    Apr 27, 2011
    Last Update Posted:
    Apr 13, 2012
    Last Verified:
    Mar 1, 2012